Finance

Lists
Why is RVU down 2,33%?
Dive Deeper
RVU:WSE
Ryvu Therapeutics SA
PLN 16,80
-2,33%
(-0,40) 1D
14 Okt., 10:40:35 GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for RVU...
Open
PLN 17,10
High
PLN 17,16
Low
PLN 16,60
Mkt. cap
388,42 m
Avg. vol.
18,00 k
Volume
5,44 k
52-wk high
PLN 31,90
52-wk low
PLN 13,64
EPS
-PLN 2,94
Shares outstanding
23,12 m
No. of employees
228
Open
PLN 17,10
High
PLN 17,16
Low
PLN 16,60
Mkt. cap
388,42 m
Avg. vol.
18,00 k
Volume
5,44 k
52-wk high
PLN 31,90
52-wk low
PLN 13,64
EPS
-PLN 2,94
Shares outstanding
23,12 m
No. of employees
228
News stories
From web sources and news partners
About Ryvu Therapeutics SA
CEO-
Employees228
Founded2007
Headquarters-
SectorHealth care
Websiteryvu.com
Last report
17 Sep. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (PLN)
16,95 m / 19,50 m
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
19,50 m
25,78 m
21,71 m
16,95 m
Cost of goods sold
3,64 m
4,08 m
4,13 m
3,52 m
Cost of revenue
3,64 m
4,08 m
4,13 m
3,52 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36,29 m
34,87 m
26,59 m
26,74 m
Operating expense
41,28 m
38,50 m
29,99 m
30,16 m
Total operating expenses
44,92 m
42,58 m
34,12 m
33,68 m
Operating income
-25,42 m
-16,80 m
-12,41 m
-16,73 m
Other non operating income
1,54 m
401,00 k
2,11 m
5,30 m
EBT including unusual items
-24,71 m
-17,52 m
-12,47 m
-12,90 m
EBT excluding unusual items
-24,73 m
-17,46 m
-12,71 m
-12,95 m
Income tax expense
-
71,00 k
180,00 k
155,00 k
Effective tax rate
-
-0,41%
-1,44%
-1,20%
Other operating expenses
1,44 m
4,33 m
1,11 m
1,42 m
Net income
-24,71 m
-17,59 m
-12,65 m
-13,06 m
Net profit margin
-126,73%
-68,22%
-58,25%
-77,02%
Earnings per share
-
-
-
-
Interest and investment income
1,28 m
891,00 k
558,00 k
670,00 k
Interest expense
-2,06 m
-2,10 m
-2,24 m
-2,05 m
Net interest expenses
-775,00 k
-1,21 m
-1,68 m
-1,38 m
Depreciation and amortization charges
2,86 m
1,87 m
2,15 m
2,00 m
EBITDA
-22,90 m
-15,15 m
-10,26 m
-14,73 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme